13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q2 2024 · Filed August 13, 2024 · Accession 0001398344-24-014514
Total Value
$6.0M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TSCAN THERAPEUTICS INC | TCRX | 630,000 | $3.7M | 61.20% |
| 2 | WEREWOLF THERAPEUTICS INC | HOWL | 589,102 | $1.4M | 23.87% |
| 3 | BARINTHUS BIOTHERAPEUTICS PL | BRNS | 642,204 | $899,086 | 14.93% |